The Board of Castlight Health, Inc. appointed John C. Doyle, James Currier and Derek Newell as members of the Board, in each case effective as of, and contingent upon, the completion of the merger. Mr. Doyle will serve as a Class III director whose current term will expire at the company's 2017 annual meeting of stockholders when the Class III directors will next be elected by the company's stockholders. Mr. Currier will serve as a Class I director whose current term will expire at the company's 2018 annual meeting of stockholders when the Class I directors will next be elected by the company's stockholders. Mr. Newell will serve as a Class II director whose current term will expire at the company's 2019 annual meeting of stockholders when the Class II directors will next be elected by the company's stockholders. Following the merger, the Board is expected to consist of: Giovanni Colella, Bryan Roberts, James Currier, John C. Doyle, Michael Eberhard, David Ebersman, Derek Newell, Ed Park, David B. Singer, and Kenny Van Zant. Dr. Roberts will resign from his position as Chairman of the Board, and Dr. Colella will be appointed as the Executive Chairman of the Board, in each case effective as of, and contingent upon the completion of the merger.